bioAffinity Technologies (NASDAQ:BIAFW) Shares Down 1.1% – Here’s What Happened

bioAffinity Technologies, Inc. (NASDAQ:BIAFW) shares traded down 1.1% on Monday . The stock traded as low as $0.3264 and last traded at $0.3264. 7 shares traded hands during trading, a decline of 100% from the average session volume of 3,036 shares. The stock had previously closed at $0.33.

bioAffinity Technologies Stock Performance

The firm has a 50 day moving average price of $0.31 and a two-hundred day moving average price of $0.33.

bioAffinity Technologies Company Profile

bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.

In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.